Literature DB >> 1253045

Rubella 1974 and its aftermath, congenital rubella syndrome.

R S Faulkner, D A Gough.   

Abstract

An epidemic of rubella reached its peak in the Atlantic provinces in 1974, subsiding in early 1975. With the exception of Quebec the remainder of Canada showed a reverse trend, with a large increase in the numbers of cases reported in the first 41/2 months of 1975. The Halifax virus laboratory reported 106 serologically proven cases of rubella in 1974, 44 of them in pregnant women. In the aftermath of the epidemic many infants were born with the congenital rubella syndrome (CRS). A study carried out from Sept. 1, 1974 through Apr. 30, 1975 showed an 80% correlation between clinical diagnosis and the presence of rubella-specific IgM antibodies in 35 of these infants. Of the 23 infants in whom the diagnosis of CRS was made by laboratory or clinical findings or both, laboratory criteria were met in 20 (87.0%), clinical criteria in 19 (82.6%) and both laboratory and clinical criteria in 16 (69.6%).

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1253045      PMCID: PMC1956819     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  5 in total

1.  Recovery of rubella virus from army recruits.

Authors:  P D PARKMAN; E L BUESCHER; M S ARTENSTEIN
Journal:  Proc Soc Exp Biol Med       Date:  1962-10

2.  Surveillance of the congenital rubella syndrome, 1969-1973.

Authors:  J F Modlin; A D Brandling-Bennett
Journal:  J Infect Dis       Date:  1974-09       Impact factor: 5.226

3.  Rubella hemagglutinin prepared with alkaline extraction of virus grown in suspension culture of BHK-21 cells.

Authors:  P E Halonen; J M Ryan; J A Stewart
Journal:  Proc Soc Exp Biol Med       Date:  1967-05

4.  A serological method for demonstrating recent infection by rubella virus.

Authors:  J E Banatvala; J M Best; E A Kennedy; E E Smith; M E Spence
Journal:  Br Med J       Date:  1967-07-29

5.  Rubella-virus hemagglutination-inhibition test.

Authors:  G L Stewart; P D Parkman; H E Hopps; R D Douglas; J P Hamilton; H M Meyer
Journal:  N Engl J Med       Date:  1967-03-09       Impact factor: 91.245

  5 in total
  4 in total

1.  Letter: Rubella in Canada.

Authors:  F White; P Varughese
Journal:  Can Med Assoc J       Date:  1976-03-20       Impact factor: 8.262

2.  Congenital rubella syndrome: continuing challenge of a preventable infection.

Authors:  A J Rhodes
Journal:  Can Med Assoc J       Date:  1977-03-05       Impact factor: 8.262

Review 3.  Prevention of congenital rubella.

Authors:  J P Welch
Journal:  Can Med Assoc J       Date:  1977-07-23       Impact factor: 8.262

4.  Effect of immune serum or polymyxin B on Escherichia coli-induced inflammation and vascular injury.

Authors:  A C Issekutz; S Bhimji; R Bortolussi
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.